BUSINESS BRIEF
Project Manila is a WHO-GMP and ISO 9001:2015 certified pharmaceutical manufacturer with over three decades of industry experience. The company’s core competency lies in the development of branded and generic formulations supported by robust R&D, efficient manufacturing, and a wide franchise-led distribution model.
The company has a strong domestic presence and is expanding rapidly in export markets including South East Asia, Africa, and the Middle East.
Business Divisions
- Pharmaceuticals
- Nutraceuticals
- Franchise Network Marketing Division
- Export & International Business Division
Products & Services
Pharmaceutical Formulations
Additional Information
Manufacturing Facilities:
-
WHO-GMP and FDA approved; conforms to revised Schedule ‘M’
-
ISO 9001:2015 Certified; GLP-certified Quality Control Lab
-
Team of 225+ skilled professionals
Proposal
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Manufacturing (Bulk Drug & API), Pharmaceutical Manufacturing (Formulation) & Pharmaceutical Manufacturing (Nutraceuticals)
Nature of Business
B2B, B2B2C, B2G
Sector
Manufacturing (Own Brand)
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Northern
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 80 - 100 Cr
Justification
FY25 EBITDA adjusted for capacity expansion and export growth
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
60.80 | 61.89 | 54.29 |
EBITDA |
|||
PAT |
